Foghorn Therapeutics Inc. (FHTX) SEC Filings — 2024

Filings

• Foghorn Therapeutics Announces Director Departure, New Appointments — 8-K · Dec 30, 2024
• Foghorn Therapeutics Files 8-K — 8-K · Dec 16, 2024
• Foghorn Therapeutics Files 8-K on Financials — 8-K · Nov 4, 2024
• Foghorn Therapeutics Files 8-K — 8-K · Oct 10, 2024
• Foghorn Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Oct 8, 2024
• Foghorn Therapeutics Inc. SC 13G Filing — SC 13G · Sep 20, 2024
• Foghorn Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Foghorn Therapeutics Files 8-K on Security Holder Votes — 8-K · Jun 26, 2024
• Foghorn Therapeutics Inc. SC 13G/A Filing — SC 13G/A · Jun 10, 2024
• Foghorn Therapeutics Files 8-K — 8-K · Jun 3, 2024
• Foghorn Therapeutics Inc. SC 13G Filing — SC 13G · May 30, 2024
• Flagship Pioneering Amends Foghorn Therapeutics Stake — SC 13D/A · May 24, 2024
• Merck to Acquire Foghorn Therapeutics for $300M — 8-K · May 23, 2024
• Foghorn Therapeutics Files 8-K: Material Agreement & Other Events — 8-K · May 22, 2024
• Foghorn Therapeutics Files 8-K — 8-K · May 20, 2024
• Foghorn Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
• Foghorn Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · May 3, 2024
• Foghorn Therapeutics Appoints New CMO, Discloses Officer Compensation — 8-K · Apr 16, 2024
• Foghorn Therapeutics Files 8-K — 8-K · Apr 9, 2024
• Foghorn Therapeutics Files 8-K — 8-K · Mar 7, 2024
• FMR LLC & Abigail Johnson Report 6.656% Stake in Foghorn Therapeutics — SC 13G/A · Feb 9, 2024
• Foghorn Therapeutics Files 8-K on Reg FD Disclosure, Other Events — 8-K · Feb 8, 2024
• Foghorn Therapeutics Files Routine 8-K on Jan 16 Event — 8-K · Jan 17, 2024
• Foghorn Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 8, 2024
• Foghorn Therapeutics Reports Officer/Director Changes, Comp Arrangements — 8-K · Jan 3, 2024